The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...
Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.
ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis Foundation to enhance its gene ...
Cystic Fibrosis Canada (CFC) is celebrating the recommendation to expand coverage to patients with at least one of 152 rare ...
More cystic fibrosis (CF) patients in Saskatchewan now have access to Trikafta, a groundbreaking medication that improves ...
"Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial" was originally created and published by ...
About Cystic Fibrosis Cystic fibrosis (CF) is a progressive genetic disease that causes persistent lung infections and respiratory failure. CF is caused by mutations in the cystic fibrosis ...
The Cystic Fibrosis Foundation is funding the development of a gene editing therapy that is designed to use ReCode’s tissue-specific delivery vehicle to transport gene editing cargo to the lung cells ...
Cahir O’Hagan from Clonoe in County Tyrone was 25 years old when he died waiting for a double lung transplant. He had cystic fibrosis, external (CF), an inherited condition that causes sticky ...
A baby born today with the recessive-gene mutation that causes cystic fibrosis has the chance to live into his or her 50s and beyond. Thanks to advances in DNA testing, doctors are identifying ...
Helping children aged two to five with the most common CF mutation gain access to the life-changing treatment, Trikafta, as a ...